APL
Altogether, our findings of USP37-modulating PLZF/RARA stability and cell transformation suggest that USP37 is a potential therapeutic target for PLZF/RARA-associated APL.
Altogether, our findings of USP37-modulating PLZF/<span class="gene" id="23208507-11-50-54">RARA</span> stability and cell transformation suggest that USP37 is a potential therapeutic target for PLZF/<span class="gene" id="23208507-11-151-155">RARA</span>-associated <span class="disease" id="23208507-11-167-170">APL</span>.